Abstract

Autoimmune thyroid diseases (AITD) are the most common group of autoimmune diseases, associated with lymphocyte infiltration and the production of thyroid autoantibodies, like thyroid peroxidase antibodies (TPOAb), in the thyroid gland. Immunoglobulins and cell-surface receptors are glycoproteins with distinctive glycosylation patterns that play a structural role in maintaining and modulating their functions. We investigated associations of total circulating IgG and peripheral blood mononuclear cells glycosylation with AITD and the influence of genetic background in a case-control study with several independent cohorts and over 3,000 individuals in total. The study revealed an inverse association of IgG core fucosylation with TPOAb and AITD, as well as decreased peripheral blood mononuclear cells antennary α1,2 fucosylation in AITD, but no shared genetic variance between AITD and glycosylation. These data suggest that the decreased level of IgG core fucosylation is a risk factor for AITD that promotes antibody-dependent cell-mediated cytotoxicity previously associated with TPOAb levels.

Highlights

  • Autoimmune thyroid diseases (AITD) are a class of chronic, organ-specific autoimmune disorders that disturb the function of the thyroid gland

  • thyroid peroxidase antibodies (TPOAb) level and AITD are associated with a decreased level of Immunoglobulin G (IgG) core fucosylation The presence of autoimmune antibodies is not a definite sign of the AITD, so we wanted to test whether IgG glycosylation status can play a role in active AITD and correlated with the TPOAb level or AITD

  • We investigated the associations between total plasma IgG glycome composition and peripheral blood TPOAb level and AITD status in 2,297 (988 controls and 1309 TPOAb positive) and 1,191 individuals (988 controls and 203 AITD) respectively from the TwinsUK cohort (Discovery Cohort; Supplementary Table 1) using hydrophilic interaction chromatography ultraperformance liquid chromatography (HILIC UPLC)

Read more

Summary

Introduction

Autoimmune thyroid diseases (AITD) are a class of chronic, organ-specific autoimmune disorders that disturb the function of the thyroid gland. They affect close to 5% of the European population (with a gender disparity) and so, represent the most common group of autoimmune diseases[1]. Except for antibodies against TSH receptors (TSAb), which are known to stimulate the production of thyroid hormones by binding TSH receptors in GD2, little is known about the role of two other thyroid autoantibodies, thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb). It is yet to be determined if anti-thyroid antibodies cause AITD, or whether additional control mechanisms, such as post-translational modifications, are required to trigger the disease onset

Objectives
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.